Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
77.930
Open
77.530
VWAP
77.54
Vol
1.67M
Mkt Cap
44.25B
Low
77.0017
Amount
129.60M
EV/EBITDA(TTM)
16.26
Total Shares
493.24M
EV
42.74B
EV/OCF(TTM)
20.16
P/S(TTM)
3.89
Alcon AG is a Switzerland-based eye care company. The Company research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The Company operates in 60 countries and serves consumers and patients in over 140 countries.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q1
FY2025Q4
FY2025Q3
2.70B
+9.14%
0.836
+14.48%
2.72B
+8.9%
0.835
+16.03%
2.60B
+5.85%
0.764
-5.64%
Estimates Revision
The market is revising Downward the revenue expectations for Alcon Inc. (ALC) for FY2025, with the revenue forecasts being adjusted by -1.11% over the past three months. During the same period, the stock price has changed by -8.23%.
Revenue Estimates for FY2025
Revise Downward
-1.11%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
-1.9%
In Past 3 Month
Stock Price
Go Down
-8.23%
In Past 3 Month
18 Analyst Rating
26.07% Upside
Wall Street analysts forecast ALC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ALC is 98.07 USD with a low forecast of 77.53 USD and a high forecast of 119.08 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
13 Buy
5 Hold
0 Sell
Moderate Buy
26.07% Upside
Current: 77.790
Low
77.53
Averages
98.07
High
119.08
26.07% Upside
Current: 77.790
Low
77.53
Averages
98.07
High
119.08
RBC Capital
Jack Reynolds-Clark
Outperform
to
Outperform
downgrade
2025-08-26
Reason
RBC Capital
Jack Reynolds-Clark
Price Target
2025-08-26
downgrade
Outperform
to
Outperform
Reason
RBC Capital analyst Jack Reynolds-Clark lowered the firm's price target on Alcon to CHF 80 from CHF 95 and keeps an Outperform rating on the shares.
UBS
Buy
to
Buy
downgrade
2025-08-26
Reason
UBS
Price Target
2025-08-26
downgrade
Buy
to
Buy
Reason
UBS lowered the firm's price target on Alcon to CHF 95 from CHF 100 and keeps a Buy rating on the shares.
Deutsche Bank
Hold
downgrade
2025-08-26
Reason
Deutsche Bank
Price Target
2025-08-26
downgrade
Hold
Reason
Deutsche Bank lowered the firm's price target on Alcon to CHF 69 from CHF 80 and keeps a Hold rating on the shares.
JPMorgan
David Adlington
Overweight
to
Neutral
downgrade
2025-08-21
Reason
JPMorgan
David Adlington
Price Target
2025-08-21
downgrade
Overweight
to
Neutral
Reason
JPMorgan analyst David Adlington downgraded Alcon to Neutral from Overweight with a price target of $77.53, down from $105.88. The company reported another "soft" quarter and cut to guidance, the analyst tells investors in a research note. The firm believes investors will now question Alcon's fiscal 2026 growth expectations. JPMorgan sees downside risk to estimates in the near term.
Wells Fargo
Larry Biegelsen
Equal Weight
downgrade
$93 -> $88
2025-08-21
Reason
Wells Fargo
Larry Biegelsen
Price Target
$93 -> $88
2025-08-21
downgrade
Equal Weight
Reason
Wells Fargo analyst Larry Biegelsen lowered the firm's price target on Alcon to $88 from $93 and keeps an Equal Weight rating on the shares. Alcon lowered its fiscal 2025 revenue guidance amid a softer cataract market and some competitive share loss, the analyst tells investors in a research note. Consensus sales estimates for 2026 likely remain intact, though expectations for margin EPS still seem optimistic, Wells says.
Stifel
Thomas Stephan
Buy
maintain
$100 -> $90
2025-08-21
Reason
Stifel
Thomas Stephan
Price Target
$100 -> $90
2025-08-21
maintain
Buy
Reason
Stifel analyst Thomas Stephan lowered the firm's price target on Alcon to $90 from $100 and keeps a Buy rating on the shares. Alcon missed on the top-line again in Q2, as the firm anticipated, and management cut 2025 constant currency sales growth guidance meaningfully, though EPS guidance was maintained. The second half appears better de-risked and management's positive tone on UNITY remains largely intact, so the firm would "tend to view this print (and guidance cut) as a clearing event of sorts," the analyst tells investors.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Alcon AG (ALC.N) is 23.67, compared to its 5-year average forward P/E of 30.06. For a more detailed relative valuation and DCF analysis to assess Alcon AG 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Undervalued
5Y Average PE
30.06
Current PE
23.67
Overvalued PE
34.06
Undervalued PE
26.06
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
Undervalued
5Y Average EV/EBITDA
18.04
Current EV/EBITDA
14.85
Overvalued EV/EBITDA
19.94
Undervalued EV/EBITDA
16.15
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Undervalued
5Y Average PS
4.12
Current PS
3.57
Overvalued PS
4.49
Undervalued PS
3.75
Financials
Annual
Quarterly
FY2025Q1
YoY :
+0.57%
2.47B
Total Revenue
FY2025Q1
YoY :
-7.28%
344.00M
Operating Profit
FY2025Q1
YoY :
+41.13%
350.00M
Net Income after Tax
FY2025Q1
YoY :
+40.00%
0.70
EPS - Diluted
FY2025Q1
YoY :
+23.23%
244.00M
Free Cash Flow
FY2025Q1
YoY :
-9.96%
50.71
Gross Profit Margin - %
FY2025Q1
YoY :
+80.07%
14.64
FCF Margin - %
FY2025Q1
YoY :
+40.24%
14.15
Net Margin - %
FY2025Q1
YoY :
-2.82%
4.83
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds areBuying! The buying amount has increased 470.5% over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
9.7K
Volume
1
6-9
Months
979.5K
Volume
6
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
8
3.0M
Volume
Months
6-9
6
516.4K
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
16.0K
USD
2
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
ALC News & Events
Events Timeline
2025-09-16 (ET)
2025-09-16
09:35:49
Staar Surgical Sends Letter to Shareholders About Alcon Merger
2025-09-16
08:12:46
Alcon Reveals Latest Time-Motion Study Findings for Unity VCS
2025-08-20 (ET)
2025-08-20
12:00:48
Alcon Experiences a 9.2% Decline
Sign Up For More Events
Sign Up For More Events
News
2.0
12:00 PMNASDAQ.COMHologic (HOLX) Rises 7.7%: Is There More Growth Potential for the Stock?
3.5
12:00 PMNASDAQ.COMAlcon's UNITY VCS Demonstrates Enhanced Efficiency in Research, Shares Rise
8.5
09-16NewsfilterSTAAR Surgical Board of Directors Fully Supports Alcon Merger as the Best Option for Maximizing Value for STAAR Shareholders
Sign Up For More News
People Also Watch
BEP
Brookfield Renewable Partners LP
25.630
USD
+1.02%
BCTX
Briacell Therapeutics Corp
9.080
USD
+5.09%
ARMN
Aris Mining Corp
9.190
USD
-3.57%
BTG
B2Gold Corp
4.320
USD
-0.23%
ARBKL
Argo Blockchain PLC
2.200
USD
+22.22%
BKT
Blackrock Income Trust Inc
11.500
USD
-0.78%
BHFAL
Brighthouse Financial Inc
18.280
USD
+0.61%
ATLCL
Atlanticus Holdings Corp
25.100
USD
+0.40%
BBU
Brookfield Business Partners LP
27.670
USD
+2.71%
FAQ
What is Alcon AG (ALC) stock price today?
The current price of ALC is 77.79 USD — it has increased 0.76 % in the last trading day.
What is Alcon AG (ALC)'s business?
What is the price predicton of ALC Stock?
What is Alcon AG (ALC)'s revenue for the last quarter?
What is Alcon AG (ALC)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Alcon AG (ALC)'s fundamentals?
How many employees does Alcon AG (ALC). have?